Azelastine and allergen transduction signal in MC9 mast cells
- PMID: 7509459
- DOI: 10.1007/BF00173212
Azelastine and allergen transduction signal in MC9 mast cells
Abstract
MC9 mast cells, sensitized with monoclonal IgE antibody specific for 2,4-dinitrophenyl (DNP) group, were exposed to DNP-BSA and the pH and cytosolic calcium signals were recorded by using the fluorescent probes BCECF and Fura-2 respectively. DNP-BSA induced cell alkalinization was fully inhibited by azelastine with IC50 (1.6 +/- 0.5 mumol/l, mean +/- SEM, n = 5) similar to that required to inhibit histamine release (1.4 mumol/l). Conversely, high azelastine concentrations (> 100 mumol/l) were required to inhibit DNP-BSA-dependent cell calcium mobilization (IC50 approximately 200 mumol/l, n = 3). Amiloride, but not the H1 histamine antagonist pyrilamine, was able to inhibit the DNP-BSA induced pH signal. In acidified mast cells, azelastine potently inhibited Na+:H+ exchange activity (IC50 = 7.7 +/- 3.6 x 10(-6) M, mean +/- SEM, n = 3). Conversely, in mouse spleen lymphocytes azelastine was unable to inhibit the amiloride-sensitive pH signal induced by concanavalin A. In conclusion, the inhibition of histamine release by azelastine is not due to an interference with the cytosolic calcium signal. Conversely, azelastine potently antagonized the allergen-dependent Na+:H+ exchange activation, suggesting an action on the protein kinase C signaling pathway.
Similar articles
-
Inhibition of calcium ionophore (A23187)-stimulated histamine release from rat peritoneal mast cells by azelastine: implications for its mode of action.Eur J Pharmacol. 1983 Dec 23;96(3-4):227-33. doi: 10.1016/0014-2999(83)90311-4. Eur J Pharmacol. 1983. PMID: 6202531
-
Inhibition by azelastine of nonallergic histamine release from rat peritoneal mast cells.J Allergy Clin Immunol. 1984 Mar;73(3):400-3. doi: 10.1016/0091-6749(84)90415-9. J Allergy Clin Immunol. 1984. PMID: 6199399
-
Inhibition of IgE-mediated allergic histamine release from rat peritoneal mast cells by azelastine and selected antiallergic drugs.Agents Actions. 1985 Jul;16(5):318-22. doi: 10.1007/BF01982866. Agents Actions. 1985. PMID: 2413739
-
Azelastine inhibits secretion of IL-6, TNF-alpha and IL-8 as well as NF-kappaB activation and intracellular calcium ion levels in normal human mast cells.Int Arch Allergy Immunol. 2003 Nov;132(3):231-9. doi: 10.1159/000074304. Int Arch Allergy Immunol. 2003. PMID: 14646384
-
Suppression of TNF-alpha secretion by azelastine in a rat mast (RBL-2H3) cell line: evidence for differential regulation of TNF-alpha release, transcription, and degranulation.J Immunol. 1997 Sep 15;159(6):2932-40. J Immunol. 1997. PMID: 9300717
Cited by
-
Intranasal azelastine. A review of its efficacy in the management of allergic rhinitis.Drugs. 1998 Jul;56(1):91-114. doi: 10.2165/00003495-199856010-00011. Drugs. 1998. PMID: 9664202 Review.
-
Calcium-pH crosstalks in rat mast cells: cytosolic alkalinization, but not intracellular calcium release, is a sufficient signal for degranulation.Br J Pharmacol. 2000 Aug;130(8):1809-16. doi: 10.1038/sj.bjp.0703490. Br J Pharmacol. 2000. PMID: 10952669 Free PMC article.